Fetal Anomalies and Long-Term Effects Associated with Substance Abuse in Pregnancy: A Literature Review

Abstract

Objectives Substance abuse in pregnancy remains a major public health problem. Fetal teratogenicity results from the effect of these substances during fetal development, particularly when used in combination. This review will focus on and attempt to clarify the existing literature regarding the association of substance abuse on the development of congenital anomalies and the long-term implications in exposed offspring.

Methods Systematic review of available English literature using the PubMed database of all peer-reviewed articles on the subject.

Results A total of 128 articles were included in this review. Alcohol was the most common substance associated with fetal anomalies, particularly facial dysmorphisms and alterations in the central nervous system development. Adverse maternal environments associated with risky behaviors and lack of adequate prenatal care precludes the timely detection of fetal anomalies, confounding most studies linking causality. In addition, although methodological differences and limited availability of well-designed trials exist, substance abuse in pregnancy has been associated with adverse long-term outcomes in infant growth, behavior, cognition, language and achievement.

Conclusion The literature summarized in this review suggests that drug exposure during pregnancy may increase the risk of congenital anomalies and long-term adverse effects in exposed children and adolescents. These conclusions must be tempered by the many confounders associated with drug use. A multidisciplinary approach is paramount for appropriate counseling regarding the known immediate and long-term risks of substance abuse in pregnancy.

Keywords

marijuana - cocaine - methadone - opioids - amphetamines - pregnancy

• References

• 1 Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13–4795. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013
• 2 Terplan M, Smith EJ, Kozloski MJ, Pollack HA. Methamphetamine use among pregnant women. Obstet Gynecol 2009; 113 (6) 1285-1291
• 3 Creanga AA, Sabel JC, Ko JY , et al. Maternal drug use and its effect on neonates: a population-based study in Washington State. Obstet Gynecol 2012; 119 (5) 924-933
• 4 Schenker S, Yang Y, Johnson RF , et al. The transfer of cocaine and its metabolites across the term human placenta. Clin Pharmacol Ther 1993; 53 (3) 329-339
• 5 Ganapathy V. Drugs of abuse and human placenta. Life Sci 2011; 88 (21-22) 926-930
• 6 Hoyme HE, Jones KL, Dixon SD , et al. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 1990; 85 (5) 743-747
• 7 van den Anker JN, Cohen-Overbeek TE, Wladimiroff JW, Sauer PJ. Prenatal diagnosis of limb-reduction defects due to maternal cocaine use. Lancet 1991; 338 (8778) 1332
• 8 Webster WS, Brown-Woodman PD. Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat. Teratology 1990; 41 (6) 689-697
• 9 Bingol N, Fuchs M, Diaz V, Stone RK, Gromisch DS. Teratogenicity of cocaine in humans. J Pediatr 1987; 110 (1) 93-96
• 10 Lutiger B, Graham K, Einarson TR, Koren G. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology 1991; 44 (4) 405-414
• 11 Addis A, Moretti ME, Ahmed Syed F, Einarson TR, Koren G. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol 2001; 15 (4) 341-369
• 12 van Gelder MMHJ, Reefhuis J, Caton AR, Werler MM, Druschel CM, Roeleveld N ; National Birth Defects Prevention Study. Maternal periconceptional illicit drug use and the risk of congenital malformations. Epidemiology 2009; 20 (1) 60-66
• 13 Lipshultz SE, Frassica JJ, Orav EJ. Cardiovascular abnormalities in infants prenatally exposed to cocaine. J Pediatr 1991; 118 (1) 44-51
• 14 Singer LT, Arendt R, Minnes S , et al. Cognitive and motor outcomes of cocaine-exposed infants. JAMA 2002; 287 (15) 1952-1960
• 15 Harvey JA. Cocaine effects on the developing brain: current status. Neurosci Biobehav Rev 2004; 27 (8) 751-764
• 16 Hurt H, Brodsky NL, Betancourt L, Braitman LE, Malmud E, Giannetta J. Cocaine-exposed children: follow-up through 30 months. J Dev Behav Pediatr 1995; 16 (1) 29-35
• 17 Covington CY, Nordstrom-Klee B, Ager J, Sokol R, Delaney-Black V. Birth to age 7 growth of children prenatally exposed to drugs: a prospective cohort study. Neurotoxicol Teratol 2002; 24 (4) 489-496
• 18 Jacobson JL, Jacobson SW, Sokol RJ. Effects of prenatal exposure to alcohol, smoking, and illicit drugs on postpartum somatic growth. Alcohol Clin Exp Res 1994; 18 (2) 317-323
• 19 Miller Jr JM, Boudreaux MC, Regan FA. A case-control study of cocaine use in pregnancy. Am J Obstet Gynecol 1995; 172 (1 Pt 1) 180-185
• 20 Richardson GA, Conroy ML, Day NL. Prenatal cocaine exposure: effects on the development of school-age children. Neurotoxicol Teratol 1996; 18 (6) 627-634
• 21 Warner TD, Behnke M, Hou W, Garvan CW, Wobie K, Eyler FD. Predicting caregiver-reported behavior problems in cocaine-exposed children at 3 years. J Dev Behav Pediatr 2006; 27 (2) 83-92
• 22 Accornero VH, Anthony JC, Morrow CE, Xue L, Bandstra ES. Prenatal cocaine exposure: an examination of childhood externalizing and internalizing behavior problems at age 7 years. Epidemiol Psichiatr Soc 2006; 15 (1) 20-29
• 23 Linares TJ, Singer LT, Kirchner HL , et al. Mental health outcomes of cocaine-exposed children at 6 years of age. J Pediatr Psychol 2006; 31 (1) 85-97
• 24 Sood BG, Nordstrom Bailey B, Covington C , et al. Gender and alcohol moderate caregiver reported child behavior after prenatal cocaine. Neurotoxicol Teratol 2005; 27 (2) 191-201
• 25 Bendersky M, Bennett D, Lewis M. Aggression at age 5 as a function of prenatal exposure to cocaine, gender, and environmental risk. J Pediatr Psychol 2006; 31 (1) 71-84
• 26 Dennis T, Bendersky M, Ramsay D, Lewis M. Reactivity and regulation in children prenatally exposed to cocaine. Dev Psychol 2006; 42 (4) 688-697
• 27 Arendt RE, Short EJ, Singer LT , et al. Children prenatally exposed to cocaine: developmental outcomes and environmental risks at seven years of age. J Dev Behav Pediatr 2004; 25 (2) 83-90
• 28 Leech SL, Richardson GA, Goldschmidt L, Day NL. Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol Teratol 1999; 21 (2) 109-118
• 29 Bandstra ES, Morrow CE, Anthony JC, Accornero VH, Fried PA. Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. Neurotoxicol Teratol 2001; 23 (6) 545-559
• 30 Savage J, Brodsky NL, Malmud E, Giannetta JM, Hurt H. Attentional functioning and impulse control in cocaine-exposed and control children at age ten years. J Dev Behav Pediatr 2005; 26 (1) 42-47
• 31 Mayes L, Snyder PJ, Langlois E, Hunter N. Visuospatial working memory in school-aged children exposed in utero to cocaine. Child Neuropsychol 2007; 13 (3) 205-218
• 32 Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 2003; 101 (2) 374-379
• 33 Bell GL, Lau K. Perinatal and neonatal issues of substance abuse. Pediatr Clin North Am 1995; 42 (2) 261-281
• 34 Musshoff F, Madea B. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit 2006; 28 (2) 155-163
• 35 Khare M, Taylor AH, Konje JC, Bell SC. Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod 2006; 12 (5) 321-333
• 36 Witter FR, Niebyl JR. Marijuana use in pregnancy and pregnancy outcome. Am J Perinatol 1990; 7 (1) 36-38
• 37 Gibson GT, Baghurst PA, Colley DP. Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy. Aust N Z J Obstet Gynaecol 1983; 23 (1) 15-19
• 38 Shaw GM, Velie EM, Morland KB. Parental recreational drug use and risk for neural tube defects. Am J Epidemiol 1996; 144 (12) 1155-1160
• 39 Hingson R, Alpert JJ, Day N , et al. Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics 1982; 70 (4) 539-546
• 40 Williams LJ, Correa A, Rasmussen S. Maternal lifestyle factors and risk for ventricular septal defects. Birth Defects Res A Clin Mol Teratol 2004; 70 (2) 59-64
• 41 Torfs CP, Velie EM, Oechsli FW, Bateson TF, Curry CJ. A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors. Teratology 1994; 50 (1) 44-53
• 42 Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 2000; 22 (3) 325-336
• 43 Fried PA. Adolescents prenatally exposed to marijuana: examination of facets of complex behaviors and comparisons with the influence of in utero cigarettes. J Clin Pharmacol 2002; 42 (Suppl. 11) 97S-102S
• 44 Fried PA, Watkinson B, Gray R. Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 2003; 25 (4) 427-436
• 45 Fried PA, Watkinson B, Gray R. Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 1998; 20 (3) 293-306
• 46 Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol 2001; 23 (1) 1-11
• 47 Fried PA, Watkinson B. Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 2001; 23 (5) 421-430
• 48 Goldschmidt L, Richardson GA, Cornelius MD, Day NL. Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicol Teratol 2004; 26 (4) 521-532
• 49 Porath AJ, Fried PA. Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicol Teratol 2005; 27 (2) 267-277
• 50 Kellogg A, Rose CH, Harms RH, Watson WJ. Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol 2011; 204 (3) e1-e4
• 51 Azadi A, Dildy III GA. Universal screening for substance abuse at the time of parturition. Am J Obstet Gynecol 2008; 198 (5) e30-e32
• 52 Broussard CS, Rasmussen SA, Reefhuis J , et al; National Birth Defects Prevention Study. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011; 204 (4) e1-e11
• 53 Markham JK, Emmerson JL, Owen NV. Teratogenicity studies of methadone HCl in rats and rabbits. Nature 1971; 233 (5318) 342-343
• 54 Jones HE, Kaltenbach K, Heil SH , et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363 (24) 2320-2331
• 55 Cleary BJ, Donnelly JM, Strawbridge JD , et al. Methadone and perinatal outcomes: a retrospective cohort study. Am J Obstet Gynecol 2011; 204 (2) e1-e9
• 56 Arlettaz R, Kashiwagi M, Das-Kundu S, Fauchère J-C, Lang A, Bucher H-U. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstet Gynecol Scand 2005; 84 (2) 145-150
• 57 Schindler SD, Eder H, Ortner R, Rohrmeister K, Langer M, Fischer G. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction 2003; 98 (1) 103-110
• 58 Welle-Strand GK, Skurtveit S, Jones HE , et al. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Drug Alcohol Depend 2013; 127 (1-3) 200-206
• 59 Zierler S, Rothman KJ. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med 1985; 313 (6) 347-352
• 60 Bracken MB. Drug use in pregnancy and congenital heart disease in offspring. N Engl J Med 1986; 314 (17) 1120
• 61 Rothman KJ, Fyler DC, Goldblatt A, Kreidberg MB. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol 1979; 109 (4) 433-439
• 62 Thomas DB. Cleft palate, mortality and morbidity in infants of substance abusing mothers. J Paediatr Child Health 1995; 31 (5) 457-460
• 63 Saxén I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol 1975; 4 (1) 37-44
• 64 Behnke M, Smith VC ; Committee on Substance Abuse; Committee on Fetus and Newborn. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics 2013; 131 (3) e1009-e1024
• 65 Shankaran S, Lester BM, Das A , et al. Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med 2007; 12 (2) 143-150
• 66 Hamilton R, McGlone L, MacKinnon JR, Russell HC, Bradnam MS, Mactier H. Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy. Br J Ophthalmol 2010; 94 (6) 696-700
• 67 Rosen TS, Johnson HL. Long-term effects of prenatal methadone maintenance. NIDA Res Monogr 1985; 59: 73-83
• 68 Lifschltz MH, Wilson GS. Patterns of growth and development in narcotic-exposed children. NIDA Res Monogr 1991; 114: 323-339
• 69 Derauf C, LaGasse LL, Smith LM , et al. Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). Am J Drug Alcohol Abuse 2007; 33 (2) 281-289
• 70 Little BB, Snell LM, Gilstrap III LC. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 1988; 72 (4) 541-544
• 71 Oei JL, Kingsbury A, Dhawan A , et al. Amphetamines, the pregnant woman and her children: a review. J Perinatol 2012; 32 (10) 737-747
• 72 McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SH. Congenital anomalies after prenatal ecstasy exposure. Lancet 1999; 354 (9188) 1441-1442
• 73 Singer LT, Moore DG, Min MO , et al. One-year outcomes of prenatal exposure to MDMA and other recreational drugs. Pediatrics 2012; 130 (3) 407-413
• 74 Singer LT, Moore DG, Fulton S , et al. Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy. Neurotoxicol Teratol 2012; 34 (3) 303-310
• 75 Milkovich L, van der Berg BJ. Effects of antenatal exposure to anorectic drugs. Am J Obstet Gynecol 1977; 129 (6) 637-642
• 76 Draper ES, Rankin J, Tonks AM , et al. Recreational drug use: a major risk factor for gastroschisis?. Am J Epidemiol 2008; 167 (4) 485-491
• 77 Chang L, Smith LM, LoPresti C , et al. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 2004; 132 (2) 95-106
• 78 Eriksson M, Jonsson B, Steneroth G, Zetterström R. Cross-sectional growth of children whose mothers abused amphetamines during pregnancy. Acta Paediatr 1994; 83 (6) 612-617
• 79 Cernerud L, Eriksson M, Jonsson B, Steneroth G, Zetterström R. Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. Acta Paediatr 1996; 85 (2) 204-208
• 80 Sokol RJ, Delaney-Black V, Nordstrom B. Fetal alcohol spectrum disorder. JAMA 2003; 290 (22) 2996-2999
• 81 Bosco C, Diaz E. Placental hypoxia and foetal development versus alcohol exposure in pregnancy. Alcohol Alcohol 2012; 47 (2) 109-117
• 82 Hankin JR, Sokol RJ. Identification and care of problems associated with alcohol ingestion in pregnancy. Semin Perinatol 1995; 19 (4) 286-292
• 83 Jones KL, Smith DW, Ulleland CN, Streissguth P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1973; 1 (7815) 1267-1271
• 84 de Sanctis L, Memo L, Pichini S, Tarani L, Vagnarelli F. Fetal alcohol syndrome: new perspectives for an ancient and underestimated problem. J Matern Fetal Neonatal Med 2011; 24 (Suppl. 01) 34-37
• 85 Polygenis D, Wharton S, Malmberg C , et al. Moderate alcohol consumption during pregnancy and the incidence of fetal malformations: a meta-analysis. Neurotoxicol Teratol 1998; 20 (1) 61-67
• 86 Henderson J, Gray R, Brocklehurst P. Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome. BJOG 2007; 114 (3) 243-252
• 87 Clarren SK, Alvord Jr EC, Sumi SM, Streissguth AP, Smith DW. Brain malformations related to prenatal exposure to ethanol. J Pediatr 1978; 92 (1) 64-67
• 88 Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, Frías JL. Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: a case-control study. Birth Defects Res A Clin Mol Teratol 2004; 70 (4) 194-200
• 89 Strömland K. Visual impairment and ocular abnormalities in children with fetal alcohol syndrome. Addict Biol 2004; 9 (2) 153-157 , discussion 159–160
• 90 Feldman HS, Jones KL, Lindsay S , et al. Prenatal alcohol exposure patterns and alcohol-related birth defects and growth deficiencies: a prospective study. Alcohol Clin Exp Res 2012; 36 (4) 670-676
• 91 DeRoo LA, Wilcox AJ, Drevon CA, Lie RT. First-trimester maternal alcohol consumption and the risk of infant oral clefts in Norway: a population-based case-control study. Am J Epidemiol 2008; 168 (6) 638-646
• 92 Mateja WA, Nelson DB, Kroelinger CD, Ruzek S, Segal J. The association between maternal alcohol use and smoking in early pregnancy and congenital cardiac defects. J Womens Health (Larchmt) 2012; 21 (1) 26-34
• 93 Davies JK, Bledsoe JM. Prenatal alcohol and drug exposures in adoption. Pediatr Clin North Am 2005; 52 (5) 1369-1393 , vii
• 94 Streissguth AP, Sampson PD, Olson HC , et al. Maternal drinking during pregnancy: attention and short-term memory in 14-year-old offspring—a longitudinal prospective study. Alcohol Clin Exp Res 1994; 18 (1) 202-218
• 95 Coles CD, Platzman KA, Raskind-Hood CL, Brown RT, Falek A, Smith IE. A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol Clin Exp Res 1997; 21 (1) 150-161
• 96 Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'Malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr 2004; 25 (4) 228-238
• 97 Nanson JL, Hiscock M. Attention deficits in children exposed to alcohol prenatally. Alcohol Clin Exp Res 1990; 14 (5) 656-661
• 98 Howell KK, Lynch ME, Platzman KA, Smith GH, Coles CD. Prenatal alcohol exposure and ability, academic achievement, and school functioning in adolescence: a longitudinal follow-up. J Pediatr Psychol 2006; 31 (1) 116-126
• 99 Kodituwakku PW, Kalberg W, May PA. The effects of prenatal alcohol exposure on executive functioning. Alcohol Res Health 2001; 25 (3) 192-198
• 100 Streissguth AP, Barr HM, Sampson PD. Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/2 years. Alcohol Clin Exp Res 1990; 14 (5) 662-669
• 101 Coles CD, Brown RT, Smith IE, Platzman KA, Erickson S, Falek A. Effects of prenatal alcohol exposure at school age. I. Physical and cognitive development. Neurotoxicol Teratol 1991; 13 (4) 357-367
• 102 Goldschmidt L, Richardson GA, Stoffer DS, Geva D, Day NL. Prenatal alcohol exposure and academic achievement at age six: a nonlinear fit. Alcohol Clin Exp Res 1996; 20 (4) 763-770
• 103 Olson HC, Streissguth AP, Sampson PD, Barr HM, Bookstein FL, Thiede K. Association of prenatal alcohol exposure with behavioral and learning problems in early adolescence. J Am Acad Child Adolesc Psychiatry 1997; 36 (9) 1187-1194
• 104 Zdravkovic T, Genbacev O, McMaster MT, Fisher SJ. The adverse effects of maternal smoking on the human placenta: a review. Placenta 2005; 26 (Suppl A): S81-S86
• 105 Little J, Cardy A, Munger RG. Tobacco smoking and oral clefts: a meta-analysis. Bull World Health Organ 2004; 82 (3) 213-218
• 106 Wyszynski DF, Duffy DL, Beaty TH. Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate Craniofac J 1997; 34 (3) 206-210
• 107 Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update 2011; 17 (5) 589-604
• 108 Feltes BC, de Faria Poloni J, Notari DL, Bonatto D. Toxicological effects of the different substances in tobacco smoke on human embryonic development by a systems chemo-biology approach. PLoS ONE 2013; 8 (4) e61743
• 109 Salmasi G, Grady R, Jones J, McDonald SD ; Knowledge Synthesis Group. Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses. Acta Obstet Gynecol Scand 2010; 89 (4) 423-441
• 110 Milne E, Greenop KR, Scott RJ , et al. Parental smoking and risk of childhood brain tumors. Int J Cancer 2013; 133 (1) 253-259
• 111 Fried PA, James DS, Watkinson B. Growth and pubertal milestones during adolescence in offspring prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 2001; 23 (5) 431-436
• 112 Kristjansson EA, Fried PA, Watkinson B. Maternal smoking during pregnancy affects children's vigilance performance. Drug Alcohol Depend 1989; 24 (1) 11-19
• 113 Fried PA, Watkinson B, Gray R. A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol. Neurotoxicol Teratol 1992; 14 (5) 299-311
• 114 Thapar A, Fowler T, Rice F , et al. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry 2003; 160 (11) 1985-1989
• 115 Kotimaa AJ, Moilanen I, Taanila A , et al. Maternal smoking and hyperactivity in 8-year-old children. J Am Acad Child Adolesc Psychiatry 2003; 42 (7) 826-833
• 116 Brook JS, Brook DW, Whiteman M. The influence of maternal smoking during pregnancy on the toddler's negativity. Arch Pediatr Adolesc Med 2000; 154 (4) 381-385
• 117 Day NL, Richardson GA, Goldschmidt L, Cornelius MD. Effects of prenatal tobacco exposure on preschoolers' behavior. J Dev Behav Pediatr 2000; 21 (3) 180-188
• 118 Wakschlag LS, Hans SL. Maternal smoking during pregnancy and conduct problems in high-risk youth: a developmental framework. Dev Psychopathol 2002; 14 (2) 351-369
• 119 Batstra L, Hadders-Algra M, Neeleman J. Effect of antenatal exposure to maternal smoking on behavioural problems and academic achievement in childhood: prospective evidence from a Dutch birth cohort. Early Hum Dev 2003; 75 (1-2) 21-33
• 120 Naeye RL. Cognitive and behavioral abnormalities in children whose mothers smoked cigarettes during pregnancy. J Dev Behav Pediatr 1992; 13 (6) 425-428
• 121 Fergusson DM, Horwood LJ, Lynskey MT. Maternal smoking before and after pregnancy: effects on behavioral outcomes in middle childhood. Pediatrics 1993; 92 (6) 815-822
• 122 Fergusson DM, Woodward LJ, Horwood LJ. Maternal smoking during pregnancy and psychiatric adjustment in late adolescence. Arch Gen Psychiatry 1998; 55 (8) 721-727
• 123 Williams GM, O'Callaghan M, Najman JM , et al. Maternal cigarette smoking and child psychiatric morbidity: a longitudinal study. Pediatrics 1998; 102 (1) e11
• 124 Räsänen P, Hakko H, Isohanni M, Hodgins S, Järvelin MR, Tiihonen J. Maternal smoking during pregnancy and risk of criminal behavior among adult male offspring in the Northern Finland 1966 Birth Cohort. Am J Psychiatry 1999; 156 (6) 857-862
• 125 Weissman MM, Warner V, Wickramaratne PJ, Kandel DB. Maternal smoking during pregnancy and psychopathology in offspring followed to adulthood. J Am Acad Child Adolesc Psychiatry 1999; 38 (7) 892-899
• 126 Fried PA, O'Connell CM, Watkinson B. 60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment. J Dev Behav Pediatr 1992; 13 (6) 383-391
• 127 Cornelius MD, Ryan CM, Day NL, Goldschmidt L, Willford JA. Prenatal tobacco effects on neuropsychological outcomes among preadolescents. J Dev Behav Pediatr 2001; 22 (4) 217-225
• 128 Fried PA, Watkinson B, Siegel LS. Reading and language in 9- to 12-year olds prenatally exposed to cigarettes and marijuana. Neurotoxicol Teratol 1997; 19 (3) 171-183